Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P06889 (
Mol
)
630,302
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
While the c-src locus is expressed as a 4.0-kilobase (kb) mRNA coding for
pp60c-src
in various chicken tissues, including embryonic muscle, it is expressed as a novel 3.0-kb mRNA in adult skeletal muscle. We have analyzed the primary structure of this alternatively transcribed and spliced c-src mRNA. The sequence revealed three open reading frames, with the previously defined c-src exons 1 through 5 or 6 comprising the third, on the 3' untranslated region of this 3-kb mRNA. The exons coding for the tyrosine kinase domain of
pp60c-src
were excluded. On the 5' side, 2 kb of sequence upstream from the previously defined exon 1 of the c-src gene was included in this mRNA. The start site for the 3-kb mRNA probably lies downstream of that for the 4-kb mRNA. The first reading frame of the 3.0-kb mRNA, called sur (for src upstream region), encoded a 24-kilodalton (kDa) protein product rich in cysteine and proline residues. In vitro analysis indicated that the 24-kDa sur protein was membrane associated. Antibodies to sur protein detected in vivo a 24-kDa muscle-specific protein which was developmentally regulated and corresponded to the switch from the 4-kb to the 3-kb c-src mRNA. A striking kinetic pattern of appearance of sur protein and disappearance of
pp60c-src
suggests that the expression of these two proteins is inversely related.
Mol
Cell Biol 1990 Aug
PMID:An alternative non-tyrosine protein kinase product of the c-src gene in chicken skeletal muscle. 211 17
The proto-oncogene product
pp60c-src
is a tyrosine-specific kinase with a still unresolved cellular function. High levels of
pp60c-src
in neurons and the existence of a neuronal
pp60c-src
variant, pp60c-srcN, suggest participation in the progress or maintenance of the differentiated phenotype of neurons. We have previously reported that phorbol esters, e.g., 12-O-tetradecanoylphorbol-13-acetate (TPA), stimulate human SH-SY5Y neuroblastoma cells to neuronal differentiation, as monitored by morphological, biochemical, and functional differentiation markers. In this report, we describe activation of the pp60src (
pp60c-src
and pp60c-srcN) kinase activity observed at 6 h after induction of SH-SY5Y cells with TPA. This phenomenon coincides in time with neurite outgrowth, formation of growth cone-like structures, and an increase of GAP43 mRNA expression, which are the earliest indications of neuronal differentiation in these cells. The highest specific src kinase activity (a three- to fourfold increase 4 days after induction) was noted in cells treated with 16 nM TPA; this concentration is optimal for development of the TPA-induced neuronal phenotype. During differentiation, there was no alteration in the 1:1 ratio of
pp60c-src
to pp60c-srcN found in untreated SH-SY5Y cells. V8 protease and trypsin phosphopeptide mapping of pp60src from in vivo 32P-labeled cells showed that the overall phosphorylation of pp60src was higher in differentiated than in untreated cells, mainly because of an intense serine 12 phosphorylation. Tyrosine 416 phosphorylation was not detectable in either cell type, and no change during differentiation in tyrosine 527 phosphorylation was observed.
Mol
Cell Biol 1990 Jan
PMID:Early activation of endogenous pp60src kinase activity during neuronal differentiation of cultured human neuroblastoma cells. 213 66
An 85,000-molecular-weight polypeptide (85K polypeptide) has previously been identified as a common substrate for tyrosine phosphorylation upon polyomavirus middle T transformation or upon platelet-derived growth factor stimulation of 3T3 cells. In each case, pp85 has an associated phosphatidylinositol kinase activity. The tissue distribution of pp85 was determined by middle T blotting experiments; the highest levels were found in brain, lung, and spleen tissues. High-resolution examination of 85K by isoelectric focusing demonstrated that there are at least 10 different forms. These were resolved into two families, 85K and 86K; the ratio of the two families changed in different cells. Similar forms were found for pp85 associated with pp60v-src. Individual species within each family differed by phosphorylation. Analysis of pp85 and pp86 by immunoprecipitation with anti-phosphotyrosine antibody showed increasing phosphorylation in response to middle T or pp60v-src transformation. The association of middle T with pp85 and
pp60c-src
was examined in pulse-chase experiments. Association of middle T with
pp60c-src
was slow and was accompanied by progressive modification of middle T. pp85 formed a dissociable complex with middle T within 2.5 min.
Mol
Cell Biol 1990 Jun
PMID:Characterization of pp85, a target of oncogenes and growth factor receptors. 216 May 90
Chicken embryo fibroblast cells overexpressing activated mutant forms of human
pp60c-src
, but not those overexpressing normal human
pp60c-src
, exhibited high levels of type I phosphatidylinositol (PI) kinase activity associated with
pp60c-src
. Levels of PI kinase activity were positively correlated with src tyrosine protein kinase activity and not with absolute levels of
pp60c-src
. Our results suggest that a linkage exists between certain forms of
pp60c-src
and the PI signal transduction pathway.
Mol
Cell Biol 1990 Jun
PMID:Association of type I phosphatidylinositol kinase activity with mutationally activated forms of human pp60c-src. 216 Jun
The polyoma middle tumor antigen (MTAg) associates with the src proto-oncogene product
pp60c-src
in infected or transformed rodent cells. The tyrosine protein kinase activity of
pp60c-src
, as measured by in vitro phosphorylation of
pp60c-src
itself or the exogenous substrate enolase, was increased 10- to 20-fold in cells transformed or infected with transformation-competent polyoma virus compared with controls.
pp60c-src
associated with MTAg and precipitated with polyoma antitumor serum had a novel site(s) of in vitro tyrosine phosphorylation within its amino-terminal domain. These observations suggest that association of MTAg with
pp60c-src
alters the accessibility of
pp60c-src
tyrosine residues for phosphorylation in vitro and increases
pp60c-src
protein kinase activity. Several transformation-defective mutants of MTAg did not cause amino-terminal tyrosine phosphorylation of
pp60c-src
in vitro or enhance its protein kinase activity, suggesting that these properties correlate with the transforming ability of MTAg. However, one transformation-defective MTAg mutant, dl1015, did cause amino-terminal tyrosine phosphorylation of
pp60c-src
in vitro and did enhance its protein kinase activity. This suggests that properties of MTAg, in addition to modifying the structure and function of
pp60c-src
, may be important for transformation.
Mol
Cell Biol 1985 Oct
PMID:Structural and functional modification of pp60c-src associated with polyoma middle tumor antigen from infected or transformed cells. 242 73
The tyrosine protein kinase activities of
pp60c-src
and pp60v-src were compared. The activities were qualitatively similar in vitro when the src proteins were bound in an immune complex with monoclonal antibody; both proteins utilized either ATP or GTP as phosphate donors, preferred Mn2+ to Mg2+, and had similar exogenous substrate specificities. The specific activity of
pp60c-src
was about 10-fold lower than that of pp60v-src for exogenous substrate phosphorylation but was only 1.1- to 2-fold lower than that of pp60v-src for autophosphorylation. Six glycolytic enzymes, including three not previously identified as substrates for pp60src phosphorylation, were phosphorylated by both
pp60c-src
and pp60v-src. Levels of
pp60c-src
fourfold higher than the amount of pp60v-src in src-plasmid-transformed cells did not detectably alter the level of phosphotyrosine in cellular proteins, but increasing the expression of
pp60c-src
another twofold (which induces cells to form foci in monolayer culture (P.J. Johnson, P.M. Coussens, A.V. Danko, and D. Shalloway,
Mol
. Cell. Biol. 5:1073-1083, 1985) resulted in a threefold increase in the level of cellular protein phosphotyrosine. Immunoprecipitation and analysis of the alkali-stable phosphoproteins by two-dimensional electrophoresis showed that, in contrast to pp60v-src-transformed cells, pp36 and enolase are only weakly phosphorylated in these high-level
pp60c-src
overexpresser cells. Even allowing for the in vitro differences in specific activities of phosphorylation, these results suggest that the
pp60c-src
tyrosine protein phosphorylating activity may be restricted relative to that of pp60v-src by additional in vivo mechanisms.
Mol
Cell Biol 1985 Oct
PMID:Restriction of the in vitro and in vivo tyrosine protein kinase activities of pp60c-src relative to pp60v-src. 242 75
Polyoma middle T antigen (mT) was expressed in rat F-111 cells under control of the dexamethasone-regulatable mouse mammary tumor virus promoter. Graded phenotypic responses to levels of mT induction by the hormone were seen, with morphological transformation, focus formation, and anchorage-independent growth requiring increasing levels of mT expression. The ability of different clones to form tumors reflected their maximum level of induction of mT-associated kinase and their ability to grow in soft agar. Expression of transformation parameters and tumorigenicity correlates with the level of mT phosphorylated by
pp60c-src
in immune complexes and not with the total amount of mT determined by metabolic labeling. We suggest that cellular factors regulate mT activity by forming a kinase-active fraction of mT molecules that controls the transformed state.
Mol
Cell Biol 1985 Sep
PMID:Regulation of cellular phenotype and expression of polyomavirus middle T antigen in rat fibroblasts. 242 83
Treatment of normal cells with the tumor promoters 12-O-tetradecanoylphorbol-13-acetate and mezerein results in increased phosphorylation of
pp60c-src
. Two-dimensional tryptic phosphopeptide analysis of partial V8 protease fragments indicated that this phosphorylation takes place on a serine residue which lies within the amino-terminal 18 kilodaltons of
pp60c-src
and represents the major phosphorylation site following tumor promoter treatment. Untreated cells exhibited a low but detectable level of phosphorylation at this serine residue. The significance of these results with respect to the phosphoregulation of
pp60c-src
as well as tumor promotion is discussed.
Mol
Cell Biol 1986 Feb
PMID:Novel serine phosphorylation of pp60c-src in intact cells after tumor promoter treatment. 243 Dec 72
We characterized the tyrosine phosphorylation sites of free
pp60c-src
and of
pp60c-src
associated with the polyomavirus middle tumor antigen (mT) in transformed avian and rodent cells. The sites of tyrosine phosphorylation in the two populations of
pp60c-src
were different, both in vitro and in vivo. Free
pp60c-src
was phosphorylated in vitro at a single site, tyrosine 416.
pp60c-src
associated with mT was phosphorylated in vitro on tyrosine 416 and on one or more additional tyrosine residues located in the amino-terminal region of the molecule. Free
pp60c-src
in polyomavirus mT-transformed cells was phosphorylated in vivo on tyrosine 527. In contrast,
pp60c-src
associated with mT was phosphorylated in vivo on tyrosine 416 and not detectably on tyrosine 527. Thus, the in vivo phosphorylation sites of
pp60c-src
associated with mT in transformed cells are identical to those of pp60v-src, the Rous sarcoma virus transforming protein. The results suggest that altered phosphorylation of
pp60c-src
associated with mT may play a role in the enhancement of the
pp60c-src
protein kinase activity and in cell transformation by polyomavirus.
Mol
Cell Biol 1986 May
PMID:Altered sites of tyrosine phosphorylation in pp60c-src associated with polyomavirus middle tumor antigen. 243 Dec 81
We have constructed a recombinant murine retrovirus which efficiently transduces avian
pp60c-src
into murine cells and which is easily rescued from infected cells in plasmid form. To characterize the virus, several randomly selected NIH 3T3 lines were isolated after infection with recombinant retroviral stocks. All lines overproduced avian
pp60c-src
and appeared morphologically normal. Immunoprecipitates made from these lines with antisera specific for
pp60c-src
were tested for their kinase activities in vitro. We find that both autokinase and enolase kinase activities increase proportionately with the level of
pp60c-src
in the immunoprecipitates. To further test the authenticity of the
pp60c-src
encoded by the retroviral vector, these analyses were repeated in the presence of polyomavirus middle T antigen. Avian
pp60c-src
was activated as a protein kinase, indicating that the virally encoded
pp60c-src
interacts normally with middle T antigen. Interestingly, by increasing the intracellular levels of
pp60c-src
15-fold over normal endogenous levels, we were unable to obtain a proportionate increase in the amount of middle-T-antigen-
pp60c-src
complex. Finally, using the shuttle features designed into the vector, we have isolated the first fully processed cDNA encoding functional avian
pp60c-src
X
pp60c-src
synthesized in vitro with this cDNA had intrinsic protein kinase activity and no detectable phosphatidylinositol kinase activity.
Mol
Cell Biol 1986 Jun
PMID:Retrovirus shuttle vector for study of kinase activities of pp60c-src synthesized in vitro and overproduced in vivo. 243 Dec 88
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>